According to IMARC Group, the global active pharmaceutical ingredients (API) market size reached USD 256.4 Billion in 2025 and is projected to reach USD 376.2 Billion by 2034, expanding at a CAGR of 4.22% during 2026–2034. This steady growth, an incremental addition of USD 119.8 Billion over nine years, reflects rising R&D investment in biologics and targeted therapies, sustained...